Indegene tops Graham discount screen at 61% despite premium P/E

Indegene tops the Graham discount screen this week. [Indegene](/stock/INDGN) (NSE: INDGN) closed at ₹555.80 against a Graham Number of ₹1278.09. That puts the margin of safety at 61.2%, the widest in our screen. It's the kind of gap that normally gets deep value attention. But the same stock carries a P/E of 33.44 and a FairStock score of 70. The arithmetic and the multiple don't seem to agree. The Graham Number comes from Ben Graham's classic formula: the square root of 22.5 times earnings per share times book value per share. It's intentionally conservative. It assumes book value is real and recoverable. In Indegene's case, the balance sheet is still heavy with cash from the May 2024 IPO. That inflates book value per share and pushes the Graham Number up to ₹1278.09. At the current price, the implied earnings per share is just over ₹16.60. So the market is not paying for the book. It's paying for future earnings. What the Graham discount actually means A 61.2% margin of safety sounds like a bargain. But the Graham Number can be flattered by a cash-heavy balance sheet. Indegene's book value isn't the same as a manufacturing company's plant and machinery. It's partly IPO proceeds waiting to be deployed. If that cash earns a low return, the book value is less valuable than the formula assumes. The market understands this and refuses to reprice the stock toward ₹1278.09. That's why the 33.44 P/E persists. Investors are pricing Indegene as a growth story, not an asset play. The FairStock score of 70 supports that view. It's above average but not in the zone where we'd call the stock a high-conviction value buy. A score above 70 means the fundamentals are balanced, but it doesn't erase a premium earnings multiple. Sector and macro pressure Indegene sits in a peculiar spot. It sells technology and analytics services to life sciences companies. US pharma budgets are under pressure from patent expiries and regulatory shifts around drug pricing. That doesn't mean spen...